By Matt Jones

NEW YORK (GenomeWeb News) – Three consumer genomics companies caught flak on Capitol Hill yesterday from lawmakers and government witnesses at a hearing focused on direct-to-consumer genetic tests and the way they are sold and marketed — and they heard about very germ-phase plans the US Food and Drug Administration may be developing to find ways to regulate them.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.